Stock Alert for Smith Micro Software Inc. (SMSI)
  • Stock Alert for Radiant Systems Inc. (RADS)
  • Stock Alert for Quantum Fuel Systems Technologies (QTWW)
  • " />

    Stock Alert for Caduceus Software Systems Corp. (CSOC)

    Caduceus Software Systems Corp. (CSOC) is a software company specializing in the development of an all-in-one solution for private practitioners and doctors with a focus in the healthcare information management industry.  CSOC was created as the Company saw an urgent need for better patient care throughout the world. General practitioners are using unsophisticated software acts as more administrative than act as a time saving tool.  The Company’s flagship product is called Caduceus MMS version 1.0 — a sophisticated appointment scheduling and patient recording software system. It has the capability to add more functionality as needed by the doctors that use it.

    Share Statistics (19-Sept-11)
    Symbol CSOC
    Current price $0.14
    52wk Range: $0.07-$0.18
    Avg Vol (3m): 49,748
    Market Cap. 37.23M
    Shares Outstanding 275.80M

    Source:, SEC Filings.

    Investment Highlights

    Shares of CSOC have gained 22.7% in the last five days; 3.9% in the last month; and 440.0% year to date.

    Shares of CSOC jumped 35% to close Monday’s session at $0.14.  More than 21 million shares traded hands during the session, dwarfing the 10-day average of just 37.3K. Over the past 52-weeks, the stock has ranged from a low of $0.07 to a high of $0.18.

    The Company early last month provided  general information on its medical records management software (MMS).  The Company said its software is targeted to provide Electronic Health Records management for practitioners and physicians, and combine it with the appointment scheduling tools useful for medical office assistants. While some software caters to specifically to doctors and some software caters specifically to their supporting staff, CSOC said its Caduceus MMS integrates these tasks together in a single software solution.

    CSOC’s product also intends to reduce paperwork, which in turn reduces chance of key stroke input error as well as other forms of human error.

    “The recent news of the American health care reform and the cost of health care in Canada and United States warrant better software to manage the flow of patient information and fast and accurate billing,” Derrick Gidden, president of CSOC stated in the press release.

    Recognizing a huge market, Gidden said there are more than 800,000 private physicians and practitioners in North America that could benefit from CSOC’s software in terms of its price point, multiple languages, tech support, and platform compatibility requirements.


    Financial Summary

    CSOC has not earned any revenues since its inception and it does not anticipate earning revenues in the upcoming quarter. The Company reported net loss for the three month period ended June 30, 2011, of approximately $5.0 million, compared to a net loss of $4.8K during the three-month period ended June 30, 2010.

    During the three months ended June 30, 2011, the Company incurred general and administrative expenses of about $13.7K, compared to $4.6K incurred during the three month period ended June 30, 2010, an increase The general and administrative expenses incurred during the three month period ended June 30, 2011 consisted of legal, accounting and reporting requirements.

    Operating expenses for the three months ended June 30, 2011, increased by 297% as compared to the comparative period in 2010, primarily as a result of signing and closing a licensing agreement with Sygnit Corp. the exclusive license to software for use in the medical industry for patient management.

    CSOC anticipates continuing to rely on equity sales of its common stock in order to continue to fund its business operations. Issuances of additional shares will result in dilution to its existing stockholders. There is no assurance that it will achieve any additional sales of its equity securities or arrange for debt or other financing to fund its planned business activities.

    Financial Strength (19-Sept-2011)




    S&P 500

    Quick Ratio (MRQ) 1.05 1.10 0.76
    Current Ratio (MRQ) 0.03 1.47 1.33 1.12
    LT Debt to Equity (MRQ) 35.62 55.32 110.87
    Total Debt to Equity (MRQ) 52.14 95.24 149.02
    Interest Coverage (TTM) -19.45 0.28 0.33 23.27

    Source:, SEC Filings.

    Analyst Consensus

    No consensus recommendations data available.

    Technical Analysis

    Comparative Analysis

    No direct competitor comparison.

    DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority.  We are neither licensed nor qualified to provide investment advice.

    The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice.  The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities.  We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

    Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.  An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report.  Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

    Any individual who chooses to invest in any securities should do so with caution.  Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested.  Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

    Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934.  Subscribers are cautioned not to place undue reliance upon these forward looking statements.  These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated.  Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC.  You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.

    We are committed to providing factual information on the companies that are profiled.  However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions.  We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so.  Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable.

    To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).

    We encourage you to invest carefully and read investment information available at the websites of the SEC at and FINRA at

    Leave a Reply

    Your email address will not be published. Required fields are marked *